Adenoviral-Vectored Multivalent Vaccine Provides Durable Protection Against Influenza B Viruses from Victoria-like and Yamagata-like Lineages
International Journal of Molecular Sciences · 12.02.2025 · 26 (4) · 1538
DOI: 10.3390/ijms26041538 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.02.2025. Verfasst von Matthew J Pekarek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68503, USA. Hauptthemen laut MEDLINE: Influenza B virus, Influenza Vaccines, Orthomyxoviridae Infections, Adenoviridae. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINR NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Despite annual vaccines, Influenza B viruses (IBVs) continue to cause severe infections and have a significant impact and burden on the healthcare system. Improving IBV vaccine effectiveness is a key focus, with various strategies under investigation. In this research, we used a computational design to select wildtype sequences for a multivalent viral-vectored vaccine (rAd-Tri-Vic) targeting the Victoria-like (Vic) hemagglutinin (HA) protein. In mouse models, the vaccine induced strong antibody and T cell responses, providing complete protection against both lineage-specific and cross-lineage (Yamagata-like) lethal challenges. The immune responses remained robust for up to six months, which demonstrated sustained protection. These results highlight the potential of HA-targeted multivalent vaccines to enhance the IBV efficacy and address protection against antigenically diverse IBV strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68503, USA.
- School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE 68503, USA.
ORCID-Profile: Matthew J Pekarek, Adthakorn Madapong, Joshua Wiggins, Eric A Weaver
Förderung
- NINR NIH HHS
- NIAID NIH HHS
- NIH HHS
- The National Institutes of Health (NIH)
- The Ruth Kirchstein T32 National Research Service Award
Zitieren
APA
Pekarek, M. J., Madapong, A., Wiggins, J., & Weaver, E. A. (2025). Adenoviral-Vectored Multivalent Vaccine Provides Durable Protection Against Influenza B Viruses from Victoria-like and Yamagata-like Lineages. International Journal of Molecular Sciences, 26(4), 1538. https://doi.org/10.3390/ijms26041538
Vancouver
Pekarek MJ, Madapong A, Wiggins J, Weaver EA. Adenoviral-Vectored Multivalent Vaccine Provides Durable Protection Against Influenza B Viruses from Victoria-like and Yamagata-like Lineages. International Journal of Molecular Sciences. 2025;26(4):1538. doi:10.3390/ijms26041538
BibTeX
@article{Pekarek2025,
author = {Pekarek, Matthew J and Madapong, Adthakorn and Wiggins, Joshua and Weaver, Eric A},
title = {Adenoviral-Vectored Multivalent Vaccine Provides Durable Protection Against Influenza B Viruses from Victoria-like and Yamagata-like Lineages},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {4},
pages = {1538},
doi = {10.3390/ijms26041538}
}
EUVIMED